These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30770504)

  • 1. OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies.
    Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham CO; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H
    J Rheumatol; 2019 Oct; 46(10):1351-1354. PubMed ID: 30770504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.
    Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Domínguez M; de Groot I; Sarver C; Lundberg IE; Bingham CO; Song YW
    J Rheumatol; 2017 Nov; 44(11):1683-1687. PubMed ID: 28765245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
    Romich E; Saygin D; DiRenzo D; Mecoli CA; de Groot I; Lodin K; Regardt M; Sarver C; Kim JY; Park JK; Beer K; Needham M; Alexanderson H; Christopher-Stine L; de Visser M; Raaphorst J;
    Semin Arthritis Rheum; 2024 Oct; 68():152534. PubMed ID: 39159576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study.
    Mecoli CA; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; Shea B; de Visser M; Song YW; Bingham CO; Christopher-Stine L
    J Rheumatol; 2019 Jan; 46(1):106-111. PubMed ID: 30219767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.
    Alexanderson H; Del Grande M; Bingham CO; Orbai AM; Sarver C; Clegg-Smith K; Lundberg IE; Song YW; Christopher-Stine L
    J Rheumatol; 2014 Mar; 41(3):581-92. PubMed ID: 24429182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
    Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
    J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set.
    Singh JA; Dowsey M; Choong PF
    BMC Musculoskelet Disord; 2017 Mar; 18(1):111. PubMed ID: 28298194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group.
    Esfandiary T; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; de Visser M; Song YW; DiRenzo D; Bingham CO; Christopher-Stine L; Mecoli CA
    Semin Arthritis Rheum; 2020 Oct; 50(5):943-948. PubMed ID: 32906029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.
    Toupin-April K; Barton JL; Fraenkel L; Meara A; Li LC; Brooks P; de Wit M; Stacey D; Légaré F; Shea B; Lyddiatt A; Hofstetter C; Christensen R; Scholte Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Karuranga S; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Beaton D; El-Miedany Y; Mittoo S; Bartlett SJ; Singh JA; Tugwell PS
    J Rheumatol; 2019 Oct; 46(10):1409-1414. PubMed ID: 30709963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
    Orbai AM; de Wit M; Mease P; Shea JA; Gossec L; Leung YY; Tillett W; Elmamoun M; Callis Duffin K; Campbell W; Christensen R; Coates L; Dures E; Eder L; FitzGerald O; Gladman D; Goel N; Grieb SD; Hewlett S; Hoejgaard P; Kalyoncu U; Lindsay C; McHugh N; Shea B; Steinkoenig I; Strand V; Ogdie A
    Ann Rheum Dis; 2017 Apr; 76(4):673-680. PubMed ID: 27613807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.
    Mackie SL; Twohig H; Neill LM; Harrison E; Shea B; Black RJ; Kermani TA; Merkel PA; Mallen CD; Buttgereit F; Mukhtyar C; Simon LS; Hill CL;
    J Rheumatol; 2017 Oct; 44(10):1515-1521. PubMed ID: 28765246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12.
    Regardt M; Basharat P; Christopher-Stine L; Sarver C; Björn A; Lundberg IE; Wook Song Y; Bingham CO; Alexanderson H
    J Rheumatol; 2015 Dec; 42(12):2492-5. PubMed ID: 25934817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.
    Smith TO; Hawker GA; Hunter DJ; March LM; Boers M; Shea BJ; Christensen R; Guillemin F; Terwee CB; Williamson PR; Dodd S; Roos EM; Loeser RF; Schnitzer TJ; Kloppenburg M; Neogi T; Ladel CH; Kalsi G; Kaiser U; Buttel TW; Ashford AE; Mobasheri A; Arden NK; Tennant A; Hochberg MC; de Wit M; Tugwell P; Conaghan PG
    J Rheumatol; 2019 Aug; 46(8):981-989. PubMed ID: 30647185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
    Lyne SA; Yip K; Vasiliou VS; Katz DA; Richards P; Tieu J; Black RJ; Bridgewater S; Palmowski A; Beaton D; Maxwell LJ; Robson JC; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2024 Feb; 64():152338. PubMed ID: 38134623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.
    Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M
    J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.
    Tieu J; Cheah JT; Black RJ; Christensen R; Ghosh N; Richards P; Robson J; Shea B; Simon LS; Singhi JA; Tugwell P; Boers M; Garibay MAA; Campochiaro C; Decary S; de Witt M; Fernandez AP; Keen HI; King L; Hinojosa-Azaola A; Hofstetter C; Gaydukova I; George MD; Gupta L; Lyne S; Makol A; Mukhtyar C; Oo WM; Petri M; Pisaniello HL; Sattui SE; Russell O; Teixeira V; Toupin-April K; Uhunmwangho C; Whitstock M; Yip K; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2021 Oct; 51(5):1139-1145. PubMed ID: 34253398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.